Italy and the city of Milan have appealed the European Council’s decision to transfer the European Medicines Agency (EMA) to Amsterdam.

The European Council picked Amsterdam as the agency’s new base during the second round of voting in November 2017. Milan had actually outpaced Amsterdam in the first round of voting. The two economic powerhouse cities had an equal amount of votes after the second round. A hat draw was used to decide the Agency’s fate, with Amsterdam having come out on top.

Italy is now arguing that the European Parliament must also have a say in the final decision. On Monday, the President of the European Parliament, Antonio Tajani, demanded a central role for the Parliament in any decision that would involve the EMA – which monitors human and animal medicinal products for the European Union – moving to the Netherlands from northern Italy.

“In order to change seat {of the EMA} you need to reform the regulation…to reform the regulation you need an ordinary legislative procedure. We’ll see what the European Parliament’s environmental committee decides, and we’ll see what the sovereign assembly decides, both of which will certainly work in the interests of European citizens,” Tajani told ANSA.

Milan’s Mayor, Giuseppe Sala, and the Governor of Lombardy, Roberto Maroni, have vowed to reverse that decision.